Lower STAT1 expression by Type I IFN receptor-deficient CD4 T cells responding against Influenza virus cannot account for reduced Th1 hallmarks compared to wildtype CD4 T cells 3138

Abstract Description Delineating how distinct cytokine signals impact the efficacy of CD4 T cell responses against Influenza A virus (IAV) is an important goal. We showed that IAV-primed STAT1-/- but not STAT4-/- CD4 T cells have reduced Th1 identity versus WT CD4 T cells. As type I interferons (IFN-I) can signal through STAT1 and STAT4, we investigated here how direct IFN-I signals impact anti-IAV CD4 T cell responses. We first compared IAV-specific WT and IFN-I receptor-deficient (IFNAR-/-) CD4 T cells in infected WT mice. Th1 hallmarks were reduced in IFNAR-/- cells, which correlated with reduced STAT1 but not STAT4 expression compared to WT cells. Furthermore, IFN-I signaling upregulated STAT1 but not STAT4 levels in WT CD4 T cells activated in vitro. To determine if STAT1 expression levels affect anti-viral CD4 T cell responses, we generated STAT1+/- CD4 T cells, which express less STAT1 than WT cells when activated in vitro, mirroring patterns seen comparing WT and IFNAR-/- effector cells. We transferred equal numbers of virus-specific WT and STAT1+/- cells to WT hosts and compared the donor cells at the peak of the T cell response after IAV infection. The Th1 identity of STAT1+/- cells mirrored that of WT CD4 T cells. This indicates that lower STAT1 expression alone cannot account for the weaker Th1 imprint of IAV-primed IFNAR-/- CD4 T cells. Our data offers insight for further studies exploring how IFN-I can be leveraged to enhance vaccine-induced antiviral T-cell immunity. Funding Sources NIH R01 grant -1R01AI167994-01 Topic Categories Viral Immunology (VIR)

Authors

Institutions

Publication Details

Journal
The Journal of Immunology
Published
2025-11-01
DOI
https://doi.org/10.1093/jimmun/vkaf283.972
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lower STAT1 expression by Type I IFN receptor-deficient CD4 T cells responding against Influenza virus cannot account for reduced Th1 hallmarks compared to wildtype CD4 T cells 3138

K. Kai McKinstry, Caroline Finn, Louise E. Kimball, Kunal Dhume et al.
The Journal of Immunology
Influenza Virus Research Studies
article

Lower STAT1 expression by Type I IFN receptor-deficient CD4 T cells responding against Influenza virus cannot account for reduced Th1 hallmarks compared to wildtype CD4 T cells 3138

K. Kai McKinstry, Caroline Finn, Louise E. Kimball, Kunal Dhume, Eugene Baffoe
article en

Abstract

Abstract Description Delineating how distinct cytokine signals impact the efficacy of CD4 T cell responses against Influenza A virus (IAV) is an important goal. We showed that IAV-primed STAT1-/- but not STAT4-/- CD4 T cells have reduced Th1 identity versus WT CD4 T cells. As type I interferons (IFN-I) can signal through STAT1 and STAT4, we investigated here how direct IFN-I signals impact anti-IAV CD4 T cell responses. We first compared IAV-specific WT and IFN-I receptor-deficient (IFNAR-/-) CD4 T cells in infected WT mice. Th1 hallmarks were reduced in IFNAR-/- cells, which correlated with reduced STAT1 but not STAT4 expression compared to WT cells. Furthermore, IFN-I signaling upregulated STAT1 but not STAT4 levels in WT CD4 T cells activated in vitro. To determine if STAT1 expression levels affect anti-viral CD4 T cell responses, we generated STAT1+/- CD4 T cells, which express less STAT1 than WT cells when activated in vitro, mirroring patterns seen comparing WT and IFNAR-/- effector cells. We transferred equal numbers of virus-specific WT and STAT1+/- cells to WT hosts and compared the donor cells at the peak of the T cell response after IAV infection. The Th1 identity of STAT1+/- cells mirrored that of WT CD4 T cells. This indicates that lower STAT1 expression alone cannot account for the weaker Th1 imprint of IAV-primed IFNAR-/- CD4 T cells. Our data offers insight for further studies exploring how IFN-I can be leveraged to enhance vaccine-induced antiviral T-cell immunity. Funding Sources NIH R01 grant -1R01AI167994-01 Topic Categories Viral Immunology (VIR)

The Journal of ImmunologyVol. 214(Supplement_1)
University of Central Florida (US), Florida College (US)
National Institutes of Health
Openalex Percentile: Top 53%
Influenza Virus Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.